1-Ethylcyclopentyl Acrylate (stabilized with MEHQ)>95.0%(GC)1g

5-Bromo-4-ethylpyrimidine, 95.0%, 10g

Pentyltriphenylphosphonium bromide, 98%, 100g

(2S)-2-Amino-2-phenylethanamide, 95.0%, 100g

2-Butoxyacetic acid, 95.0%, 10g

1-[(2,3-difluorophenyl)methyl]-1H-pyrazol-4-amine, 95.0%, 1g

2,7-Diiodofluorene>98.0%(GC)1g

(R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,5-dimethoxyphenyl)propanoic acid, 98%, 250mg

(5-(N-cyclopropylsulfamoyl)-2-methoxyphenyl)boronic acid, 95+%, 250mg

2-((Difluoromethyl)thio)benzo[d]thiazole, 97%, 1g

GC capillary column ROTI®Cap-1701 MS, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

4-Chloro-6-methylthieno[2,3-d]pyrimidine, 95.0%, 250mg

Benzenesulfonamide, 4-dodecyl-N-1,3,4-thiadiazol-2-yl-, 98%, 50mg